Literature DB >> 36221005

Outcomes of Local Excision Compared to Radical Excision of Rectal Gastrointestinal Stromal Tumors: A Propensity-Score Matched Analysis of the NCDB.

Sameh Hany Emile1,2, Nir Horesh1,3, Michael R Freund1,4, Zoe Garoufalia1, Rachel Gefen1, Emanuela Silva-Alvarenga1, Steven D Wexner5.   

Abstract

BACKGROUND: Gastrointestinal stromal tumors (GISTs) account for <1% of gastrointestinal cancers. The present study aimed to assess the outcomes of local and radical excision of non-metastatic rectal GISTs.
METHODS: This study was a retrospective cohort analysis of patients with non-metastatic rectal GISTs in the NCDB. Patients were divided according to the surgical approach into local and radical excision and were compared in regard to the baseline characteristics and outcomes. A propensity-score matched analysis was performed to match the two groups for baseline confounders. The main outcomes were 5-year overall survival (OS), surgical margins, hospital stay, short-term mortality, and readmission.
RESULTS: 228 patients (54.8% male) with rectal GISTs were included. Before matching, 127 (55.7%) patients underwent local excision and 101 (44.3%) had radical excision. Patients who underwent local excision had more cT1-T2 and low-grade GISTs whereas patients who had radical excision received more neoadjuvant systemic treatment. After matching for clinical T stage, tumor grade, and neoadjuvant systemic therapy, 52 patients were included in each group. Local excision had a significantly higher rate of positive resection margins (42.2% vs. 19.1%, p = 0.02) and a shorter hospital stay (0 vs. 3 days, p < 0.001) than radical excision. The two groups had similar mean OS (139.8 vs. 133.1 months, p = 0.52).
CONCLUSIONS: Local excision was associated with a significantly higher incidence of positive resection margins and shorter hospital stay, yet similar overall survival to radical excision.
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Entities:  

Year:  2022        PMID: 36221005     DOI: 10.1007/s00268-022-06778-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  5 in total

1.  Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors.

Authors:  Ying-Yong Hou; Shao-Hua Lu; Yang Zhou; Wei-Dong Qi; Yuan Shi; Yun-Shan Tan; Xiong-Zeng Zhu
Journal:  Mod Pathol       Date:  2009-02-27       Impact factor: 7.842

Review 2.  Is the Surgical Margin in Gastrointestinal Stromal Tumors Different?

Authors:  Piotr Rutkowski; Jacek Skoczylas; Piotr Wisniewski
Journal:  Visc Med       Date:  2018-08-24

Review 3.  Neoadjuvant Therapy to Downstage the Extent of Resection of Gastrointestinal Stromal Tumors.

Authors:  Jens Jakob; Peter Hohenberger
Journal:  Visc Med       Date:  2018-10-09

4.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.

Authors:  Peter C Austin
Journal:  Multivariate Behav Res       Date:  2011-06-08       Impact factor: 5.923

5.  Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research.

Authors:  Abhishek Kumar; Zachary D Guss; Patrick T Courtney; Vinit Nalawade; Paige Sheridan; Reith R Sarkar; Matthew P Banegas; Brent S Rose; Ronghui Xu; James D Murphy
Journal:  JAMA Netw Open       Date:  2020-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.